Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Clinical & Surgical Translation of Adult Stem Cells

Nathan Bryan's Biography



Nathan Bryan, Professor, Baylor College of Medicine

Dr. Nathan S. Bryan is an Adjunct Professor within the Department of Molecular and Human Genetics at Baylor College of Medicine in Houston. Dr. Bryan earned his undergraduate Bachelor of Science degree in Biochemistry from the University of Texas at Austin and his doctoral degree from Louisiana State University School of Medicine in Shreveport where he was the recipient of the Dean’s Award for Excellence in Research. He pursued his post-doctoral training as a Kirschstein Fellow at Boston University School of Medicine in the Whitaker Cardiovascular Institute. Dr. Bryan has been involved in nitric oxide research for the past 15 years and has made many seminal discoveries in the field. These discoveries and findings have transformed diagnosis and treatment of many chronic diseases associated with NO insufficiency. Dr. Bryan is also an entrepreneur and has successfully commercialized several of his discoveries. He has five issued US patents and 6 pending worldwide. Dr. Bryan is the founder and Chief Science Officer of Neogenis Labs, a Texas based company started to commercialize nitric oxide based technologies and diagnostics.

Nathan Bryan Image

The Role of Nitric Oxide in Regenerative Medicine

Monday, 9 November 2015 at 11:20

Add to Calendar ▼2015-11-09 11:20:002015-11-09 12:20:00Europe/LondonThe Role of Nitric Oxide in Regenerative MedicineClinical and Surgical Translation of Adult Stem Cells in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Nitric oxide (NO) is a ubiquitous cell signaling molecule responsible for a host of physiological events, including regulation of blood pressure, neurotransmission and host defense.  Most recently NO has been identified as the requisite signal for stem cell mobilization and differentiation.  The presentation will discuss how NO is regulated and produced in the body and what leads to endothelial dysfunction and insufficient NO production.  New safe and effective therapeutics will be discussed that have been clinically proven to restore and replete NO production in humans.  These strategies will enhance stem cell therapies and lead to better outcomes in patients.


Add to Calendar ▼2015-11-09 00:00:002015-11-10 00:00:00Europe/LondonClinical and Surgical Translation of Adult Stem CellsClinical and Surgical Translation of Adult Stem Cells in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com